Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

OM:LYKO A
OM:LYKO ASpecialty Retail

Lyko Group (OM:LYKO A) Stock Faces Q2 Profit Test For Bullish Turnaround Narrative

Lyko Group (OM:LYKO A) has released its Q2 2026 numbers with revenue of SEK 1,025 million and basic EPS of SEK 2.04, alongside net income of SEK 31.3 million. This puts a cleaner quarterly profit print in front of investors after a mixed run of prior results. The company has seen quarterly revenue move between SEK 827.2 million and SEK 1,279.2 million over the past six reported periods, while basic EPS has ranged from a loss of SEK 1.43 to a profit of SEK 2.04. This sets up Q2 as an important...
OB:PARB
OB:PARBBanks

Pareto Bank (OB:PARB) Stock Faces Margin Compression Challenging Bullish Growth Narratives

Pareto Bank (OB:PARB) has released its Q2 2026 numbers, reporting total revenue of NOK 97.9 million and net income of NOK 36.9 million. Trailing twelve month revenue stands at NOK 751.6 million and net income at NOK 358.4 million. Over recent quarters the bank’s quarterly revenue has moved from NOK 326.1 million in Q2 2025 to NOK 97.9 million in Q2 2026, while net income shifted from NOK 187.7 million to NOK 36.9 million. This sets the backdrop for investors who are focused on how profit...
NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Zai Lab (ZLAB) Rebounds Sharply, Is The Valuation Gap An Opportunity?

Zai Lab (ZLAB) is back in focus after a recent share price move, with the stock closing at US$20.20. Investors are weighing this level against the company’s current fundamentals and recent performance. See our latest analysis for Zai Lab. Over a longer window, Zai Lab’s 11.11% 1 month share price return contrasts with a decline of 20% over 3 months and a 39.83% fall in 1 year total shareholder return. This suggests recent momentum is attempting to recover following a weak stretch. If you are...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

Adobe (ADBE) Could Be 26% Below Fair Value After 8 Quarters Of Revenue Growth

Adobe (ADBE) is drawing attention after posting eight consecutive quarters of revenue growth while managing executive transitions and pushing AI deeper into its software. This combination stands out as recurring revenue margins come under pressure. See our latest analysis for Adobe. Despite the latest 1-month share price return of 21.57% and a 7-day share price return of 6.09%, Adobe’s year to date share price return is down 28.82%, and the 1-year total shareholder return has declined 35.14%...
NYSE:HPQ
NYSE:HPQTech

Should HP’s Expanded Latin America AI Education Push Shape HPQ Investors’ View on Its Innovation Strategy?

Goodwall recently expanded its partnership with HP Inc. to extend HP devices and AI skills programs across Brazil and Latin America, including AI Fundamentals and the NextGen AI Alliance, with content now available in Brazilian Portuguese and Spanish. The initiative has already reached more than two million young people in over 180 countries and awarded over 151,000 HP-branded credentials, aligning HP with large-scale AI education and future workforce development. Next, we’ll examine how...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Is Bayer (XTRA:BAYN) Cheap After Its Clinical Trial Partnerships?

Bayer (XTRA:BAYN) is drawing fresh investor attention after announcing multi institution partnerships with Henry Ford Health and the University of Colorado Anschutz, UCHealth and Children’s Hospital Colorado to expand and speed up clinical trials. See our latest analysis for Bayer. Bayer’s recent clinical trial alliances arrive as momentum in the stock has picked up, with a 30 day share price return of 28.07% and a year to date share price return of 27.53%. The 1 year total shareholder return...
OM:RATO B
OM:RATO BCapital Markets

Ratos (OM:RATO B) Stock Jumps To Profit With Q2 EPS Beat Challenging Bear Narratives

Ratos (OM:RATO B) has put fresh numbers on the table for Q2 2026, reporting revenue of SEK5.97b and basic EPS of SEK3.18, with net income excluding extra items at SEK1.04b. The company has seen quarterly revenue move from SEK5.59b in Q2 2025 to SEK5.97b in Q2 2026, while EPS shifted from SEK0.94 to SEK3.18 over the same period, setting up a very different earnings profile versus last year. For investors, the key question now is how durable these margins look given the recent history of losses...
OM:SAAB B
OM:SAAB BAerospace & Defense

Saab (OM:SAAB B) Stock Faces Rich Valuation As 36.5% Earnings Growth Fuels Bullish Narratives

Saab (OM:SAAB B) has just posted its Q2 2026 scorecard, with revenue of SEK25.5b and basic EPS of SEK3.98, set against trailing twelve month figures of SEK88.2b in revenue and SEK13.20 in EPS that have been growing at 30.4% per year over the past five years and 36.5% over the last year. Over recent quarters, revenue has moved from SEK19.8b in Q2 2025 to SEK27.7b in Q4 2025, then to SEK19.2b in Q1 2026 and SEK25.5b in Q2 2026, while quarterly basic EPS has ranged from SEK1.78 to SEK4.76 across...
NYSE:DELL
NYSE:DELLTech

Dell Technologies (DELL) Could Be 18% Undervalued Following Bylaw Changes

Dell Technologies (DELL) recently amended its bylaws to opt into Section 21.373 of the Texas Business Organizations Code, setting specific ownership, holding period, and solicitation thresholds for shareholders who want to submit proposals. See our latest analysis for Dell Technologies. Those bylaw changes arrive after a sharp run up in Dell Technologies, with the share price at $396.34 and a very large year to date share price return of 210.13%, alongside a multi year total shareholder...
NYSE:AA
NYSE:AAMetals and Mining

Palantir Stock And 2 Low Risk Picks Backed By Strong Balance Sheets

Markets are sending mixed signals right now, with softer inflation readings, uneven housing data and shifting global bond flows all pulling your portfolio in different directions. When headlines are noisy, low risk leaders with strong balance sheets can help you stay invested without leaning on guesswork about the next macro swing. Our Low-Risk Leaders screener focuses on companies that our model scores as having the lowest risk profiles, so you can concentrate on resilient businesses instead...
NYSE:IMAX
NYSE:IMAXEntertainment

Is IMAX (IMAX) Undervalued Following The Odyssey Buzz And New In Vehicle Partnership?

IMAX (IMAX) is back in focus after two catalysts: the upcoming Christopher Nolan film "The Odyssey," shot entirely on IMAX 70mm cameras, and a new in-vehicle entertainment partnership with Goer Dynamics and IMAX China. See our latest analysis for IMAX. After a softer 30 day share price return, down 11.46%, IMAX is still showing renewed interest, with a 90 day share price return of 9.18% and a 1 year total shareholder return of 38.11%, supported by fresh content and platform expansion news. If...
NYSE:PNC
NYSE:PNCBanks

PNC (PNC) Stock Looks Reasonable Even After A 109% Rally

PNC Financial Services Group has delivered a strong 108.8% share price return over the past 3 years, and the current valuation picture now hinges on how that rally lines up with its intrinsic value estimate and broader checks. The 108.8% 3 year return suggests investors have already priced in a meaningful improvement in PNC Financial Services Group's earnings power. Recent earnings growth, a higher dividend, and ongoing technology investment can support higher valuations, while integration...
SWX:RIEN
SWX:RIENMachinery

Rieter Holding (SWX:RIEN) Stock Faces EPS Loss As Profit Recovery Narrative Is Tested

Rieter Holding (SWX:RIEN) has reported H1 2026 revenue of CHF 576.7 million alongside a basic EPS loss of CHF 0.41 and a net income loss of CHF 55.5 million, with trailing twelve month revenue at CHF 925.6 million and a net income loss of CHF 98.8 million framing the broader earnings picture. Over the last three reported half years, the company has seen revenue move from CHF 336.2 million in H1 2025 to CHF 348.9 million in H2 2025 and then to CHF 576.7 million in H1 2026. Basic EPS moved from...
NasdaqGS:KURA
NasdaqGS:KURABiotechs

Is Kura Oncology (KURA) Turning Darlifarnib Into a Foundational Precision Combo Platform?

Kura Oncology previously announced that updated Phase 1a results from its FIT-001 trial of darlifarnib plus cabozantinib in advanced renal cell carcinoma were selected for an oral presentation at the 2026 Kidney Cancer Research Summit in Boston. The data highlight darlifarnib’s potential to enhance VEGFR-targeted therapies by inhibiting adaptive mTORC1 signaling, supporting Kura’s plan to position it as a precision combination backbone across multiple targeted therapy classes. We’ll now...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

Is Extreme Networks (EXTR) Fully Valued Following Investor Letter Praise For Its AI And Wi Fi 7 Story?

Investor Letter Puts Extreme Networks Back in Focus Extreme Networks (EXTR) drew fresh attention after Madison Small Cap Fund highlighted the company in its Q2 2026 investor letter, citing its cloud-managed, software-defined platform and differentiation against larger networking competitors. The fund also pointed to industry shifts toward Wi-Fi 7 and broader AI deployments as potential drivers for Extreme Networks’ hardware and software management solutions, a backdrop that has coincided with...
SEHK:867
SEHK:867Pharmaceuticals

Samsara Stock And 2 Founder Led Software Picks With Real Revenue Growth

Founder led companies can offer something many investors value in a world of shifting inflation data, mixed growth signals, and frequent policy surprises: leaders whose own reputations and long term vision are closely tied to shareholder outcomes. With global rates, energy costs, and consumer demand all pulling markets in different directions, backing founders who remain deeply invested in their business can be one way to focus on execution rather than headlines. This article highlights 3...
OM:SKF B
OM:SKF BMachinery

SKF (OM:SKF B) Stock Faces Margin Weakness That Tests Bullish Growth Narratives

AB SKF (OM:SKF B) has just reported Q2 2026 results, with revenue of SEK23.2b and basic EPS of SEK2.77 as investors weigh those numbers against a trailing net profit margin of 5.0% and a current share price of SEK249.10. The company has seen quarterly revenue move from SEK23.2b in Q2 2025 to SEK23.2b in Q2 2026, while quarterly basic EPS shifted from SEK1.13 to SEK2.77 over the same period as trailing twelve month EPS reached SEK9.89. With earnings having declined at about 7.7% per year over...
OM:SVIK
OM:SVIKCommercial Services

Studsvik (OM:SVIK) Stock Margins Improve To 3.4% Challenging Earnings Volatility Narrative

Studsvik (OM:SVIK) has reported Q2 2026 revenue of 247 million SEK with basic EPS of 0.89 SEK, set against a trailing twelve month net profit margin of 3.4% compared with 1.1% a year earlier. Over recent quarters the company has seen revenue move from 205.8 million SEK in Q3 2025 to 222.9 million SEK in Q4 2025, 226.4 million SEK in Q1 2026 and 247 million SEK in Q2 2026, while quarterly basic EPS has ranged from 0.44 SEK to 1.83 SEK over that period. With trailing twelve month earnings up...
HLSE:ALBAV
HLSE:ALBAVBanks

Ålandsbanken Abp (HLSE:ALBAV) Stock Faces Margin Compression That Tests Bullish Narratives

Ålandsbanken Abp (HLSE:ALBAV) has reported Q2 2026 numbers with total revenue of €53.4 million and basic EPS of €0.62, providing context for how investors may assess the latest quarter against a share price of €46.2. Over recent periods the bank has seen quarterly revenue move in a relatively narrow range between €52.2 million and €56.6 million, while basic EPS has ranged from €0.62 to €0.95. This offers a clear view of how top line and per share earnings have tracked together through the...
NYSE:ACM
NYSE:ACMConstruction

How Investors Are Reacting To AECOM (ACM) Winning New Global Rail, Bridge And Water Contracts

In July 2026, AECOM announced a series of major contract wins, including roles on Queensland’s The Wave rail project, Canada’s Alexandra Bridge replacement, and Thames Water’s approximately £340 million Oxford Sewage Treatment Works upgrade. These appointments highlight AECOM’s growing involvement in complex, digitally delivered transport and water projects that are tightly linked to regulatory, sustainability and infrastructure-planning priorities across multiple regions. We’ll now examine...
ASX:NXL
ASX:NXLSoftware

3 Legal Services Stocks Benefiting From Rising Compliance Demand

Legal and regulatory stocks are suddenly in the spotlight as the Department of Justice turns up the heat on major law firms that cut deals with the Trump administration. For investors, this tension can reshape how capital flows into legal services, compliance, and risk management businesses that sit close to the action but outside the subpoena line. This article looks at 3 stocks from our Legal and Regulatory Services Sector screener that are exposed to the current news, all with potential...
NasdaqGS:CEG
NasdaqGS:CEGElectric Utilities

Constellation Energy (CEG) Faces New York Power Constraints, Is The Stock Below Fair Value?

New York’s one year moratorium on environmental permits for large data centers has pushed power constraints into focus, putting Constellation Energy (CEG) under closer investor scrutiny as AI driven electricity demand meets regulatory limits. See our latest analysis for Constellation Energy. Constellation Energy’s share price has cooled recently, with the stock down 7.9% over the past month and 12.2% over the past quarter, while its 1 year total shareholder return is down 21.1% after a very...